Activation of the kallikrein-kinin system by cardiopulmonary bypass in humans

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 281, Issue 4 50-4, 2001, Pages

  Campbell, Duncan J ^a,c   Dixon, Barry ^a   Kladis, Athena ^a   Kemme, Michael ^b   Santamaria, John D ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

^c ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Angiotensin converting enzyme inhibition; Aprotinin; Bradykinin; Contact system; Kallidin; Kallistatin; Kininogen

Indexed keywords

APROTININ; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH MOLECULAR WEIGHT KININOGEN; KALLIDIN; KALLIKREIN; KININ; LOW MOLECULAR WEIGHT KININOGEN;

ADULT; AGED; ARTICLE; BIOLOGICAL MODEL; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HEART SURGERY; HUMAN; KALLIKREIN KININ SYSTEM; MALE; OPERATION DURATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0034796973     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2001.281.4.r1059     Document Type: Article

References (49)

1. 1 receptors as a new inflammatory target. Could this B the 1?
2. Reduction of blood activation in patients receiving aprotinin during cardiopulmonary bypass for coronary artery surgery
3. Bioregulation of kinins: Kallikreins, kininogens, and kininases
4. Endothelial cell injury in cardiovascular surgery: The systemic inflammatory response
5. Angiotensin converting enzyme inhibition modifies angiotensin, but not kinin peptide levels in human atrial tissue
6. Strategies for measurement of angiotensin and bradykinin peptides and their metabolites in central nervous system and other tissues
7. Kallistatin, a novel human tissue kallikrein inhibitor: Levels in body fluids, blood cells, and tissues in health and disease
8. Differential interactions of human kallikrein-binding protein and α1-anti-trypsin with human tissue kallikrein
9. Contact system: A vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes
10. Cardiopulmonary bypass increases plasma bradykinin concentrations
11. Kinins in humans
12. Heparin binding of protein-C inhibitor - Analysis of the effect of heparin on the interaction of protein-C inhibitor with tissue kallikrein
13. Inhibition of tissue kallikrein by protein C inhibitor. Evidence for identity of protein C inhibitor with the kallikrein binding protein
14. Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127) - Results of a randomized, double-blind, placebo-controlled trial
15. Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs
16. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects
17. Role of endogenous bradykinin in human coronary vasomotor control
18. Assembly of contact-phase factors on the surface of the human neutrophil membrane
19. Aprotinin concentrations effective for the inhibition of tissue kallikrein and plasma kallikrein in vitro and in vivo
20. Hydroxylated kininogens and kinins
21. Isolation and identification of hydroxyproline analogues of bradykinin in human urine
22. Identification of immunoreactive tissue prokallikrein on the surface membrane of human neutrophils
23. Aprotinin inhibits thrombin formation and monocyte tissue factor in simulated cardiopulmonary bypass
24. Different activation patterns in the plasma kallikrein-kinin and complement systems during coronary bypass surgery
25. Inhibition of the activation of Hageman factor (factor XII) by aprotinin (Trasylol)
26. Long-term angiotensin-converting enzyme inhibitor treatment attenuates adrenergic responsiveness without altering hemodynamic control in patients undergoing cardiac surgery
27. Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans
28. Effect of bradykinin B2-receptor antagonism on post-ischemic coronary reperfusion
29. Plasma bradykinin in angio-oedema
30. An autoantibody to human plasma prekallikrein blocks activation of the contact system
31. Increased circulating bradykinin during hypothermia and cardiopulmonary bypass in children
32. High-molecular-weight kininogen is a binding protein for tissue prokallikrein
33. Basic pharmacology of kinins: Pharmacologic receptors and other mechanisms
34. Beneficial effects of a bradykinin antagonist in a model of gram-negative sepsis
35. Kininogen changes in human plasma following a test meal or insulin administration
36. Activation of the fibrinolytic, coagulation and plasma kallikrein-kinin systems during and after open heart surgery in children
37. Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease
38. Contact activation: A revision
39. Plasma kallikrein/kinin system: A revised hypothesis for its activation and its physiologic contributions
40. Immunoreactive tissue kallikrein in human serum
41. Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass
42. Bradykinin in open heart surgery: Metabolism of bradykinin in the coronary circulation during reperfusion
43. Western blot analyses of prekallikrein and its activation products in human plasma
44. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface
45. Selective kallikrein inhibitors alter human neutrophil elastase release during extracorporeal circulation
46. Formation of C1s-C1-inhibitor, kallikrein-C1-inhibitor, and plasmin- α2-plasmin-inhibitor complexes during cardiopulmonary bypass
47. Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies
48. FXII levels, FXIIa-like activities and kallikrein activities in normal subjects and patients undergoing cardiac surgery
49. Localization and expression of tissue kallikrein and kallistatin in human blood vessels